Dale G. Ando

2014

In 2014, Dale G. Ando earned a total compensation of $1.3M as Vice President, Therapeutic Development and Chief Medical Officer at Sangamo Biosciences, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$143,220
Option Awards$404,895
Salary$440,000
Stock Awards$351,750
Total$1,339,865

Ando received $440K in salary, accounting for 33% of the total pay in 2014.

Ando also received $143.2K in non-equity incentive plan, $404.9K in option awards and $351.8K in stock awards.

Rankings

In 2014, Dale G. Ando's compensation ranked 6,283rd out of 13,032 executives tracked by ExecPay. In other words, Ando earned more than 51.8% of executives.

ClassificationRankingPercentile
All
6,283
out of 13,032
52nd
Division
Manufacturing
2,288
out of 4,965
54th
Major group
Chemicals And Allied Products
768
out of 1,690
55th
Industry group
Drugs
601
out of 1,369
56th
Industry
Biological Products, Except Diagnostic Substances
115
out of 241
52nd
Source: SEC filing on April 25, 2016.

Ando's colleagues

We found four more compensation records of executives who worked with Dale G. Ando at Sangamo Biosciences in 2014.

2014

Edward Lanphier

Sangamo Biosciences

Chief Executive Officer

2014

Geoffrey Nichol

Sangamo Biosciences

Former Executive Vice President, Research and Development

2014

Philip Gregory

Sangamo Biosciences

Chief Scientific Officer

2014

H Wolff

Sangamo Biosciences

Chief Financial Officer

You may also like